Abstract
The regulation of the secretion of hormones from the anterior pituitary gland depends, to a large degree, on the release of substances from the hypothalamus into the hypophysial portal vessels of the median eminence. These neural substances act in conjunction with other blood-borne substances from the periphery to regulate the function of the various anterior pituitary cells. Thus far, the only hypothalamic substances that have been unequivocally demonstrated are the peptides; thyrotropin-releasing hormone (TRH), luteinizing hormone-releasing hormone (LHRH) and somatostatin (or GHRIH). In addition, most evidence favours the supposition that dopamine is the major prolactin inhibitory factor (PIF), although there have been sporadic reports of a separate PIF (notably GABA). Dopamine acts directly on pituitary cells to inhibit prolactin secretion, it is found in the portal blood in concentrations sufficient to affect prolactin release, and its release from the hypothalamus appears to be influenced by effectors of prolactin secretion in vivo. There is also evidence for the existence of corticotropin-releasing factor (CRF), growth hormone releasing factor (GRF), and a prolactin releasing factor (PRF). This latter activity may be distinct from TRH which also stimulates prolactin secretion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected bibliography
Azhar, S., and Menon, K.M.J., 1977, Cyclic nucleotide phosphodiesterases from rat anterior pituitary: Characteriseion of multiple forms and regulation by protein activator and Ca, Eur. J. Biochem., 73: 73–82.
Barnes, G.D., Brown, B.L., Gard, T.G., Atkinson, D., and Ekins, R.P., 1978, Effect of TRH and dopamine on cyclic AMP levels in enriched mammotroph and thyrotroph cells, Mol. Cell Endocr., 12: 273–284.
Conn, P.M., Morrell, D.V., Dufau, M.L., and Catt, K.J., 1979, Gonadotropin-releasing hormone action in cultured pituicytes: Independence of luteinizing hormone release and adenosine 3’,5’monophosphate production, Endocrinology, 104: 448–453.
DeCamilli, P., Macconi, D., and Spada, A., 1979, Dopamine inhibits adenylate cyclase in human prolactin secreting pituitary adenomas, Nature, 278: 252–254.
Faure, N., Cronin, M.J., Martial, J.A., and Weiner, R.I., 1980, Decreased responsiveness of GH cells to the dopamine inhibition of prolactin, Endocrinology, 107: 1022–1026.
Gautvik, K.M., Iverse24 J-G., and Sand, 0., 1980, On the role of extracellular Ca for prolactin release and adenosine 3’,5’- monophosphate formation induced by thyroliberin in cultured rat pituitary cells, Life Sci., 26: 995–1005.
Gershengorn, M.C., Marcus-Samuels. B.E., and Geras, E., 1979, Estrogens increase the number of thyrotropin-releasing hormone receptors on mammotropic cells in culture, Endocrinology, 105: 171–176.
Gershengorn, M.C., Rebecchi, M.J., Geras, E., and Arevalo, C.O., 1980, Thyrotropin-releasing hormone (TRH) action in mouse thyrotropic tumour cells in culture: Evidence against a role for adenosine 3’,5’ monophosphate as a mediator of TRH-stimulated thyrotropin release, Endocrinology, 107: 665–670.
Heindel, J.J., and Clement-Cormier, Y.C., 1981, Regulation of adenylate cyclase activity in GH cells by chlorpromazine and a heat-stable factor, Endocrinology, 108: 310–317.
Labrie, F., Borgeat, P., Drouin, J., Beaulieu, M., Lagace, L., Ferland, L., and Raymond, V., 1979, Mechanism of action of hypothalamic hormones in the adenohypophysis, Ann. Rev. Physiol.41:555–569.
Naor, Z., Zor, U., Meidan, R., and Koch, Y, 1978, Sex difference in pituitary cyclic AMP response to gonadotropin-releasing hormone, Am. J. Physiol., 235: E37 - E41.
Naor, Z., Snyder, G.., Fawcett, C.P., and McCann, S.M., 1980, Pituitary cyclic nucleotides and thyrotropin-releasing hormone action: The relationship of adenosine 3’,5’ monophosphate and guanosine 3’,5’ monophosphate to the release of thyrotropin and prolactin, Endocrinology, 106: 1304–1310.
Ozawa, S., and Kimura, N., 1979, Membrane potential changes caused by thyrotropin-releasing hormone in the clonal GH3 cell and their relationship to secretion of pituitary hormone, Proc. Natl. Acad. Sci, USA, 76: 6017–6020.
Ray, K.P., and Wallis, M., 1981, Effects of dopamine on prolactin secretion and cyclic AMP accumulation in rat anterior pituitary gland, Biochem. J., 194: 119–128.
Schrey, M.P., Brown, B.L., and Ekins, R.P., 1978, Studies on the role of calcium and cyclic nucleotides in the control of TSH secretion, Mol. Cell. Endocr., 11: 249–264.
Stefanini, E., Clement-Cormier, Y.C., Vernaleone, F., Devoto, p., Marchisio, A.M., and Collu, R., 1981, Sodium-dependent interaction of benzamides with dopamine receptors in rat and dog anterior pituitary glands, Neuroendocrinology, 32: 103–107.
Taraskevich, P.S., and Douglas, W.W., 1977, Action potentials occur in cells of the normal anterior pituitary gland and are stimulated by the hypophysiotropic peptide thyrotropin-releasing hormone, Proc. Natl. Acad. Sci. USA, 74: 4064–4067.
Taraskevich, P.S., and Douglas, W.W., 1978, Catecholamines of supposed inhibitory hypophysiotropic function suppress action potentials in prolactin cells, Nature, 276: 832–834.
Thorner, M.O., Hackett, J.T., Murad, F., and MacLeod, R.M., 1980, Calcium rather than cyclic AMP as the physiological intracellular regulator of prolactin release, Neuroendocrinology, 31: 390–402.
West, B., and Dannies, P.S, 1979, Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor,Endocrinology, 104: 877–880.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brown, B.L., Dobson, P.R.M. (1982). Intracellular Signals in Pituitary Hormone Secretion. In: Swillens, S., Dumont, J.E. (eds) Cell Regulation by Intracellular Signals. NATO Advanced Study Institutes Series, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7718-4_25
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7718-4_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7720-7
Online ISBN: 978-1-4684-7718-4
eBook Packages: Springer Book Archive